title: [Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells].
authors.forename: Masashi
authors.initials: M
authors.lastname: Asai
authors.forename: Keiro
authors.initials: K
authors.lastname: Shirotani
authors.forename: Takayuki
authors.initials: T
authors.lastname: Kondo
authors.forename: Haruhisa
authors.initials: H
authors.lastname: Inoue
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Iwata
mesh_terms: D000544:Alzheimer Disease / Q000145:classification / Q000188:drug therapy* / Q000235:genetics*; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors / Q000502:physiology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation; D004281:Docosahexaenoic Acids / Q000494:pharmacology / Q000627:therapeutic use; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D009154:Mutation; D009474:Neurons / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects; D057285:Precision Medicine; D055503:Protein Multimerization
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D004281:Docosahexaenoic Acids; D053829:Amyloid Precursor Protein Secretases